Analyst Consensus ?
ConsensusBuy95 ratings
Bullish7376.8%
Neutral2021.1%
Bearish22.1%
1 unmapped firm rating excluded from the percentages.
Salesforce, Inc. · CRM · FY2027 Q1 · Calendar Q2 2026
Salesforce Q1 FY27: Record Revenue as BrentForce AI Crosses $1B ARR
Salesforce's Q1 FY27 delivered a record $11.13B in revenue (up 13% YoY) and a 24% EPS beat, powered by explosive adoption of its BrentForce agentic AI platform, which crossed $1B in ARR. Management raised FY27 revenue guidance to $45.9-$46.2B and reaffirmed its FY30 'Rule of 50' framework. Despite the strong print, the stock drifted approximately 10% lower in the weeks following the report, suggesting investors are questioning whether surging AI usage metrics (28.6T tokens, 3.8B agentic work units) will translate into durable bookings growth -- particularly with softness persisting in Commerce Cloud and Tableau. The gap between the current $181.50 share price and the $265.75 analyst consensus target reflects this tension between demonstrated AI momentum and unresolved monetization questions.
Reported After market closeNYSETechnology
$142.18B market cap
100quality score
Company context
Snapshot as of publicationSalesforce, Inc. is a leading provider of customer relationship management (CRM) solutions, dedicated to connecting businesses and their clientele on a global scale. At its core, the Customer 360 platform empowers organizations to create seamless, integrated experiences for their customers. The company's extensive suite of services encompasses a wide array of functionalities: Sales: Tools designed to manage sales pipelines, track leads, forecast opportunities, extract data-driven insights through analytics, and streamline the creation of quotes, contracts, and invoices. Service: Capabilities enabling companies to deliver highly personalized, trustworthy, and scalable customer support. Platform: A versatile development environment, featuring intuitive drag-and-drop tools, that allows businesses of diverse sizes, locations, and industries to build tailored applications, thereby strengthening customer relationships. Learning: An online educational platform providing accessible training to acquire sought-after Salesforce skills.…
Earnings scorecard
Reported versus consensus
Reported EPS
$3.88
Consensus $3
EPS surprise
+24.0%
Reported versus consensus
Reported revenue
$11.13B
Consensus $11.05B
Revenue surprise
+0.7%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$209.06Current
$119Low
$270.4Average
$675High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Aug 24, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Guggenheim | Buy | Buy | Maintain | Aug 20, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Aug 20, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 20, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 18, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Aug 12, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 12, 2026 |
| Morgan Stanley | Equal Weight | Overweight | Downgrade | Jul 21, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 14, 2026 |
| Keybanc | Overweight | Downgrade | Jul 9, 2026 | |
| Needham | Buy | Buy | Maintain | Jun 16, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Jun 16, 2026 |
| Wedbush | Outperform | Outperform | Maintain | May 28, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 28, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | May 28, 2026 |
| Macquarie | Neutral | Neutral | Maintain | May 28, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | May 28, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | May 28, 2026 |
| BTIG | Buy | Buy | Maintain | May 28, 2026 |
| Bernstein | Underperform | Underperform | Maintain | May 28, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 28, 2026 |
| B. Riley Securities | Buy | Buy | Maintain | May 28, 2026 |
| Northland Capital Markets | Market Perform | Market Perform | Maintain | Mar 10, 2026 |
| Stifel | Buy | Buy | Maintain | Feb 26, 2026 |
| Roth Capital | Buy | Buy | Maintain | Feb 26, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Feb 26, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Feb 26, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Feb 26, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 26, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 23, 2026 |
| Truist Securities | Buy | Buy | Maintain | Dec 4, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Dec 4, 2025 |
| Baird | Outperform | Outperform | Maintain | Dec 4, 2025 |
| B of A Securities | Buy | Buy | Maintain | Nov 17, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 17, 2025 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | May 30, 2025 |
| WestPark Capital | Buy | Buy | Maintain | May 29, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | May 29, 2025 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Mar 17, 2025 |
| Loop Capital | Hold | Hold | Maintain | Feb 27, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Feb 24, 2025 |
| Erste Group | Buy | Hold | Upgrade | Nov 19, 2024 |
| Phillip Securities | Accumulate | Buy | Maintain | Aug 30, 2024 |
| Roth MKM | Buy | Buy | Maintain | Aug 29, 2024 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Aug 29, 2024 |
| Wolfe Research | Outperform | Outperform | Maintain | Apr 16, 2024 |
| Argus Research | Buy | Buy | Maintain | Mar 6, 2024 |
| Societe Generale | Hold | Buy | Downgrade | Jun 1, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 21, 2023 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Jan 13, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Dec 5, 2022 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Nov 17, 2022 |
| Cleveland Research | Neutral | Buy | Downgrade | Sep 28, 2022 |
| CICC | Outperform | Outperform | Maintain | May 9, 2022 |
| Redburn Partners | Buy | Buy | Maintain | Jun 28, 2021 |
| KGI Securities | Neutral | Neutral | Maintain | Jun 2, 2021 |
| CFRA | Strong Buy | Strong Buy | Maintain | Jun 1, 2020 |
| Rosenblatt | Sell | Sell | Maintain | May 5, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Aug 23, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Aug 23, 2019 |
| Nomura | Buy | Buy | Maintain | Aug 23, 2019 |
| Compass Point | Buy | Buy | Maintain | Aug 13, 2019 |
| Exane BNP Paribas | Outperform | Outperform | Maintain | Mar 29, 2019 |
| Pivotal Research | Buy | Hold | Upgrade | Jan 7, 2019 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 21, 2018 |
| Argus | Buy | Buy | Maintain | Aug 31, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | May 5, 2018 |
| Monness Crespi Hardt | Buy | Buy | Maintain | Apr 11, 2018 |
| Bank of America | Buy | Buy | Maintain | Nov 8, 2017 |
| Moffett Nathanson | Buy | Buy | Maintain | Sep 6, 2017 |
| Benchmark | Outperform | Outperform | Maintain | Apr 27, 2017 |
| Drexel Hamilton | Buy | Buy | Maintain | Dec 19, 2016 |
| OTR Global | Positive | Mixed | Upgrade | Nov 15, 2016 |
| Wunderlich Securities | Buy | Buy | Maintain | Sep 1, 2016 |
| Wunderlich | Buy | Buy | Maintain | Sep 1, 2016 |
| MKM Partners | Buy | Buy | Maintain | May 19, 2016 |
| FBN Securities | Outperform | Outperform | Maintain | May 19, 2016 |
| Brean Capital | Buy | Buy | Maintain | May 19, 2016 |
| CLSA | Buy | Outperform | Maintain | Feb 10, 2016 |
| Pacific Crest | Overweight | Overweight | Maintain | Nov 19, 2015 |
| Lake Street | Buy | Buy | Maintain | Nov 9, 2015 |
| BTIG Research | Buy | Buy | Maintain | Sep 10, 2015 |
| Northland Securities | Outperform | Outperform | Maintain | Jul 8, 2015 |
| Susquehanna | Positive | Positive | Maintain | May 21, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | May 20, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Oct 3, 2014 |
| D.A. Davidson | Neutral | Neutral | Maintain | Oct 2, 2014 |
| B. Riley | Neutral | Neutral | Maintain | May 16, 2014 |
| Barrington Research | Outperform | Outperform | Maintain | Feb 26, 2014 |
| Janney Capital | Neutral | Neutral | Maintain | Oct 22, 2013 |
| Argus Capital | Buy | Buy | Maintain | Oct 17, 2013 |
| First Analysis | Overweight | Overweight | Maintain | Aug 20, 2013 |
| Global Equities Research | Overweight | Overweight | Maintain | Aug 16, 2013 |
| Maxim Group | Buy | Buy | Maintain | Jan 29, 2013 |
| Longbow Research | Neutral | Neutral | Maintain | Dec 14, 2012 |
| ThinkEquity | Buy | Buy | Maintain | Jul 13, 2012 |
| Bank oferica | Buy | Buy | Maintain | Feb 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $209.06. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Monness | Brian White | $222 | $193.76 | +6.2% | Aug 13, 2026 |
| Cantor Fitzgerald | Matthew VanVliet | $250 | $179.52 | +19.6% | May 28, 2026 |
| Piper Sandler | Billy Fitzsimmons | $215 | $179.7 | +2.8% | May 28, 2026 |
| Roth Capital | Richard Baldry | $325 | $177.51 | +55.5% | May 28, 2026 |
| KeyBanc | Jackson Ader | $290 | $178.8 | +38.7% | May 28, 2026 |
| Truist Financial | Terry Tillman | $280 | $199.84 | +33.9% | Feb 26, 2026 |
| Oppenheimer | Brian Schwartz | $250 | $191.75 | +19.6% | Feb 26, 2026 |
| Goldman Sachs | Gabriela Borges | $281 | $191.75 | +34.4% | Feb 26, 2026 |
| BMO Capital | Keith Bachman | $235 | $187.34 | +12.4% | Feb 20, 2026 |
| Mizuho Securities | Gregg Moskowitz | $340 | $261.02 | +62.6% | Dec 10, 2025 |
| UBS | Karl Keirstead | $260 | $247.92 | +24.4% | Dec 4, 2025 |
| RBC Capital | Rishi Jaluria | $250 | $247.87 | +19.6% | Dec 4, 2025 |
| Needham | Scott Berg | $400 | $238.72 | +91.3% | Dec 4, 2025 |
| Oppenheimer | Brian Schwartz | $300 | $230.66 | +43.5% | Dec 1, 2025 |
| Roth Capital | Analyst unavailable | $395 | $244.01 | +88.9% | Sep 4, 2025 |
| UBS | Keith Weiss | $404 | $259.5 | +93.2% | Jun 18, 2025 |
| BMO Capital | Keith Bachman | $350 | $277.03 | +67.4% | May 28, 2025 |
| UBS | Brad Sills | $350 | $283.42 | +67.4% | May 22, 2025 |
| Cantor Fitzgerald | Carter Gould | $210 | $250.48 | +0.4% | Apr 23, 2025 |
| Piper Sandler | Brent Bracelin | $405 | $326.84 | +93.7% | Jan 21, 2025 |
| CFRA | Aaron Siegel | $380 | $331.01 | +81.8% | Dec 2, 2024 |
| BMO Capital | Keith Bachman | $385 | $326.69 | +84.2% | Nov 15, 2024 |
| CFRA | Aaron Siegel | $343 | $291.11 | +64.1% | Oct 17, 2024 |
| Northland Securities | Nehal Chokshi | $400 | $280.06 | +91.3% | Oct 2, 2024 |
| Piper Sandler | Brent Bracelin | $325 | $264.21 | +55.5% | Sep 24, 2024 |
| Bank of America Securities | Brad Sills | $325 | $261.95 | +55.5% | Sep 20, 2024 |
| Robert W. Baird | Rob Oliver | $315 | $265.99 | +50.7% | Sep 20, 2024 |
| Barclays | Raimo Lenschow | $305 | $252.43 | +45.9% | Sep 19, 2024 |
| Goldman Sachs | Kash Rangan | $325 | $253.37 | +55.5% | Sep 12, 2024 |
| Jefferies | Brent Thill | $350 | $242.66 | +67.4% | Sep 6, 2024 |
| Needham | Scott Berg | $345 | $246.12 | +65.0% | Sep 6, 2024 |
| RBC Capital | Rishi Jaluria | $300 | $259.41 | +43.5% | Aug 29, 2024 |
| Truist Financial | Terry Tillman | $300 | $218.01 | +43.5% | May 30, 2024 |
| CFRA | Aaron Siegel | $300 | $218.01 | +43.5% | May 30, 2024 |
| BMO Capital | Keith Bachman | $265 | $218.22 | +26.8% | May 30, 2024 |
| Roth Capital | Richard Baldry | $335 | $271.62 | +60.2% | May 30, 2024 |
| Oppenheimer | Brian Schwartz | $280 | $218.18 | +33.9% | May 30, 2024 |
| Mizuho Securities | Gregg Moskowitz | $300 | $271.62 | +43.5% | May 30, 2024 |
| Goldman Sachs | Kash Rangan | $315 | $271.62 | +50.7% | May 30, 2024 |
| Evercore ISI | Kirk Materne | $330 | $269.83 | +57.8% | May 29, 2024 |
| RBC Capital | Rishi Jaluria | $350 | $278.57 | +67.4% | May 24, 2024 |
| Wells Fargo | Michael Turrin | $300 | $277.87 | +43.5% | May 23, 2024 |
| Oppenheimer | Brian Schwartz | $325 | $283.82 | +55.5% | May 23, 2024 |
| Goldman Sachs | Kash Rangan | $345 | $286.77 | +65.0% | May 20, 2024 |
| BMO Capital | Keith Bachman | $335 | $276.64 | +60.2% | Apr 16, 2024 |
| Wedbush | Daniel Ives | $325 | $303.07 | +55.5% | Feb 29, 2024 |
| Morgan Stanley | Keith Weiss | $350 | $300.39 | +67.4% | Feb 26, 2024 |
| Evercore ISI | Kirk Materne | $290 | $251.9 | +38.7% | Nov 30, 2023 |
| Needham | Mike Cikos | $675 | $230.35 | +222.9% | Nov 30, 2023 |
| Truist Financial | Terry Tillman | $275 | $230.46 | +31.5% | Nov 29, 2023 |
| Loop Capital Markets | Keith Bachman | $252 | $224.5 | +20.5% | Nov 21, 2023 |
| Needham | Scott Berg | $250 | $221.96 | +19.6% | Aug 31, 2023 |
| Piper Sandler | Brent Bracelin | $248 | $213.88 | +18.6% | Aug 30, 2023 |
| BMO Capital | Keith Bachman | $255 | $226.79 | +22.0% | Jul 12, 2023 |
| Oppenheimer | Brian Schwartz | $235 | $214.16 | +12.4% | Jun 1, 2023 |
| Needham | Scott Berg | $230 | $188.6 | +10.0% | Mar 2, 2023 |
| Atlantic Equities | Analyst unavailable | $140 | $147.76 | -33.0% | Jan 13, 2023 |
| Bernstein | Mark Moerdler | $119 | $147.44 | -43.1% | Jan 11, 2023 |
| Piper Sandler | Analyst unavailable | $171 | $140.51 | -18.2% | Jan 9, 2023 |
| Morgan Stanley | Analyst unavailable | $228 | $128.04 | +9.1% | Dec 19, 2022 |
| Robert W. Baird | Rob Oliver | $150 | $130.48 | -28.3% | Dec 8, 2022 |
| Citigroup | Tyler Radke | $164 | $133.28 | -21.6% | Dec 5, 2022 |
| Credit Suisse | Analyst unavailable | $225 | $144.56 | +7.6% | Dec 5, 2022 |
| Wells Fargo | Michael Turrin | $175 | $143.83 | -16.3% | Dec 1, 2022 |
| Jefferies | Analyst unavailable | $230 | $145.16 | +10.0% | Dec 1, 2022 |
| Canaccord Genuity | Analyst unavailable | $180 | $145.16 | -13.9% | Dec 1, 2022 |
| Truist Financial | Analyst unavailable | $210 | $145.19 | +0.4% | Dec 1, 2022 |
| Cowen & Co. | Analyst unavailable | $195 | $144.9 | -6.7% | Dec 1, 2022 |
| Wedbush | Analyst unavailable | $200 | $144.15 | -4.3% | Dec 1, 2022 |
| Deutsche Bank | Analyst unavailable | $200 | $144.12 | -4.3% | Dec 1, 2022 |
| Barclays | Analyst unavailable | $180 | $144.12 | -13.9% | Dec 1, 2022 |
| Morgan Stanley | Analyst unavailable | $250 | $144.44 | +19.6% | Dec 1, 2022 |
| BMO Capital | Analyst unavailable | $172 | $143.98 | -17.7% | Dec 1, 2022 |
| J.P. Morgan | Analyst unavailable | $200 | $145.08 | -4.3% | Dec 1, 2022 |
| RBC Capital | Analyst unavailable | $200 | $160.25 | -4.3% | Dec 1, 2022 |
| Atlantic Equities | Analyst unavailable | $200 | $160.25 | -4.3% | Dec 1, 2022 |
| UBS | Analyst unavailable | $162 | $160.25 | -22.5% | Dec 1, 2022 |
| Raymond James | Analyst unavailable | $200 | $160.25 | -4.3% | Dec 1, 2022 |
| Oppenheimer | Analyst unavailable | $185 | $160.25 | -11.5% | Dec 1, 2022 |
| Barclays | Raimo Lenschow | $193 | $151.68 | -7.7% | Nov 30, 2022 |
| Wells Fargo | Analyst unavailable | $190 | $144.85 | -9.1% | Nov 22, 2022 |
| Jefferies | Brent Thill | $250 | $150.15 | +19.6% | Sep 22, 2022 |
| JMP Securities | Patrick Walravens | $250 | $150.15 | +19.6% | Sep 22, 2022 |
| RBC Capital | Rishi Jaluria | $235 | $150.15 | +12.4% | Sep 22, 2022 |
| BMO Capital | Keith Bachman | $207 | $170.31 | -1.0% | Aug 25, 2022 |
| Raymond James | Brian Peterson | $202 | $169.21 | -3.4% | Aug 25, 2022 |
| Wedbush | Nick Setyan | $264 | $180.01 | +26.3% | Aug 25, 2022 |
| BMO Capital | Keith Bachman | $207 | $173.91 | -1.0% | Aug 25, 2022 |
| Stifel Nicolaus | J. Parker Lane | $200 | $180.01 | -4.3% | Aug 25, 2022 |
| Evercore ISI | Kirk Materne | $225 | $180.01 | +7.6% | Aug 25, 2022 |
| JMP Securities | Patrick Walravens | $250 | $173.91 | +19.6% | Aug 25, 2022 |
| J.P. Morgan | Mark Murphy | $245 | $173.91 | +17.2% | Aug 25, 2022 |
| Piper Sandler | Brent Bracelin | $200 | $180.01 | -4.3% | Aug 25, 2022 |
| RBC Capital | Rishi Jaluria | $235 | $180.01 | +12.4% | Aug 25, 2022 |
| Wells Fargo | Michael Turrin | $220 | $180.01 | +5.2% | Aug 25, 2022 |
| Wedbush | Daniel Ives | $215 | $173.91 | +2.8% | Aug 25, 2022 |
| Robert W. Baird | Robert Oliver | $230 | $180.01 | +10.0% | Aug 25, 2022 |
| Citigroup | Tyler Radke | $179 | $180.01 | -14.4% | Aug 25, 2022 |
| Bank of America Securities | Bradley Sills | $210 | $180.01 | +0.4% | Aug 25, 2022 |
| Piper Sandler | Brent Bracelin | $200 | $173.91 | -4.3% | Aug 25, 2022 |
| Societe Generale | Richard Nguyen | $235 | $173.91 | +12.4% | Aug 25, 2022 |
| Wells Fargo | Michael Turrin | $220 | $173.91 | +5.2% | Aug 25, 2022 |
| Morgan Stanley | Keith Weiss | $273 | $190.09 | +30.6% | Aug 16, 2022 |
| Credit Suisse | Phil Winslow | $315 | $184.91 | +50.7% | Jun 4, 2022 |
| BMO Capital | Keith Bachman | $225 | $160.24 | +7.6% | Jun 1, 2022 |
| J.P. Morgan | Mark Murphy | $275 | $160.24 | +31.5% | Jun 1, 2022 |
| Jefferies | Brent Thill | $260 | $176.07 | +24.4% | Jun 1, 2022 |
| JMP Securities | Patrick Walravens | $250 | $176.07 | +19.6% | Jun 1, 2022 |
| Wells Fargo | Michael Turrin | $235 | $176.07 | +12.4% | Jun 1, 2022 |
| Citigroup | Tyler Radke | $192 | $176.07 | -8.2% | Jun 1, 2022 |
| J.P. Morgan | Mark Murphy | $275 | $176.07 | +31.5% | Jun 1, 2022 |
| Wells Fargo | Michael Turrin | $235 | $160.24 | +12.4% | Jun 1, 2022 |
| Wedbush | Daniel Ives | $225 | $176.07 | +7.6% | Jun 1, 2022 |
| RBC Capital | Rishi Jaluria | $235 | $160.24 | +12.4% | Jun 1, 2022 |
| BMO Capital | Keith Bachman | $225 | $176.07 | +7.6% | Jun 1, 2022 |
| Robert W. Baird | Robert Oliver | $260 | $176.07 | +24.4% | Jun 1, 2022 |
| Stifel Nicolaus | J. Parker Lane | $250 | $176.07 | +19.6% | Jun 1, 2022 |
| Monness | Brian White | $225 | $176.07 | +7.6% | Jun 1, 2022 |
| Piper Sandler | Brent Bracelin | $250 | $176.07 | +19.6% | Jun 1, 2022 |
| RBC Capital | Rishi Jaluria | $235 | $176.07 | +12.4% | Jun 1, 2022 |
| Oppenheimer | Brian Schwartz | $205 | $165.1 | -1.9% | May 31, 2022 |
| Jefferies | Brent Thill | $260 | $160.32 | +24.4% | May 24, 2022 |
| Barclays | Raimo Lenschow | $208 | $159.65 | -0.5% | May 21, 2022 |
| Mizuho Securities | Gregg Moskowitz | $225 | $158.26 | +7.6% | May 19, 2022 |
| Morgan Stanley | Keith Weiss | $291 | $166.91 | +39.2% | May 16, 2022 |
| KeyBanc | Michael Turits | $223 | $175.94 | +6.7% | May 1, 2022 |
| Jefferies | Brent Thill | $330 | $170.84 | +57.8% | Apr 25, 2022 |
| Robert W. Baird | Robert Oliver | $300 | $184.82 | +43.5% | Apr 21, 2022 |
| Piper Sandler | Brent Bracelin | $330 | $204.75 | +57.8% | Mar 3, 2022 |
| Stifel Nicolaus | J. Parker Lane | $300 | $210.39 | +43.5% | Mar 2, 2022 |
| UBS | Karl Keirstead | $225 | $210.39 | +7.6% | Mar 2, 2022 |
| Citigroup | Tyler Radke | $233 | $210.39 | +11.5% | Mar 2, 2022 |
| J.P. Morgan | Mark Murphy | $316 | $210.39 | +51.2% | Mar 2, 2022 |
| Bank of America Securities | Bradley Sills | $300 | $210.39 | +43.5% | Mar 2, 2022 |
| RBC Capital | Rishi Jaluria | $325 | $210.39 | +55.5% | Mar 2, 2022 |
| Evercore ISI | Kirk Materne | $300 | $210.39 | +43.5% | Mar 2, 2022 |
| BMO Capital | Keith Bachman | $260 | $210.39 | +24.4% | Mar 2, 2022 |
| Goldman Sachs | Kash Rangan | $360 | $208.89 | +72.2% | Mar 1, 2022 |
| Barclays | Raimo Lenschow | $275 | $208.89 | +31.5% | Mar 1, 2022 |
| Jefferies | Brent Thill | $360 | $208.89 | +72.2% | Mar 1, 2022 |
| Deutsche Bank | Brad Zelnick | $300 | $208.89 | +43.5% | Mar 1, 2022 |
| Morgan Stanley | Keith Weiss | $360 | $210.53 | +72.2% | Feb 28, 2022 |
| Cowen & Co. | Derrick Wood | $285 | $210.53 | +36.3% | Feb 28, 2022 |
| Stifel Nicolaus | Parker Lane | $350 | $208.09 | +67.4% | Feb 26, 2022 |
| Wells Fargo | Michael Turrin | $265 | $204.29 | +26.8% | Feb 24, 2022 |
| Mizuho Securities | Gregg Moskowitz | $295 | $196.84 | +41.1% | Feb 20, 2022 |
| Goldman Sachs | Kash Rangan | $340 | $196.84 | +62.6% | Feb 18, 2022 |
| Loop Capital Markets | Yun Kim | $225 | $216.97 | +7.6% | Feb 7, 2022 |
| Barclays | Raimo Lenschow | $290 | $231.23 | +38.7% | Jan 16, 2022 |
| UBS | Karl Keirstead | $265 | $227.67 | +26.8% | Jan 5, 2022 |
| Truist Financial | Terry Tillman | $330 | $251.5 | +57.8% | Dec 1, 2021 |
| Atlantic Equities | Peter Sazel | $360 | $296.84 | +72.2% | Nov 22, 2021 |
| Norddeutsche Landesbank | Wolfgang Donie | $275 | $254.37 | +31.5% | Sep 14, 2021 |
| Societe Generale | Richard Nguyen | $321 | $266.53 | +53.5% | Aug 27, 2021 |
| Roth Capital | Richard Baldry | $242 | $267.79 | +15.8% | Aug 26, 2021 |
| Wolfe Research | Alex Zukin | $300 | $267.79 | +43.5% | Aug 26, 2021 |
| FBN Securities | Shebly Seyrafi | $310 | $267.79 | +48.3% | Aug 26, 2021 |
| Bernstein | Mark Moerdler | $290 | $267.79 | +38.7% | Aug 26, 2021 |
| KGI Securities | Freddy Chen | $330 | $267.79 | +57.8% | Aug 26, 2021 |
| Macquarie | Frederick Havemeyer | $280 | $244.27 | +33.9% | Jun 30, 2021 |
| Redburn Partners | Neil Steer | $320 | $244.57 | +53.1% | Jun 28, 2021 |
| Daiwa | Satoshi Tanaka | $285 | $237.48 | +36.3% | Jun 4, 2021 |
Track every rating change on CRM the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
-0.8%
Event window
SPY move
+0.6%
Same window
Abnormal move
-1.3%
Stock minus SPY
Volume
1.8×
Versus trailing sessions
Subsequent drift
-10.1%
Up to 20 sessions
CRMSPY benchmark
Follow CRM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Versus the prior quarter (FY26 Q4), Salesforce rebranded its agentic AI offering as BrentForce (formerly Agentforce), now an $800M business powering 250,000+ consumer engagements per quarter. AI token consumption surged from 19 trillion to 28.6 trillion (+152% QoQ), and agentic work units rose from 2.4B to 3.8B. The company introduced Headless 360 as a new API-first strategy and previewed BrentForce Voice and Coworker agents. FY27 revenue guidance was raised to $45.9-$46.2B, building on the prior quarter's FY30 revenue target of $63B and $50B buyback authorization. The bullish score from transcript analysis increased from 85 to 92.
Guidance delta
FY27 revenue guidance raised to $45.9-$46.2B. Management reaffirmed the FY30 revenue target of $63B and introduced a 'Rule of 50' framework targeting double-digit revenue growth combined with margin expansion. The prior quarter had also raised guidance, lifting the FY30 revenue target to $63B alongside a $50B share buyback authorization.
Key takeaways
- Record Q1 revenue of $11.13B, up 13% YoY, with strong operating margin expansion and a 24% EPS beat.
- BrentForce agentic AI surpassed $1B ARR; the platform processed 28.6 trillion AI tokens (+152% QoQ) and generated 3.8B agentic work units.
- Headless 360 introduced as an API-first strategy, opening Salesforce to new surfaces and developer ecosystems.
- Slack AI usage surged with active usage units up 350% QoQ; management projected agents on Slack will outnumber human users.
- FY27 revenue guidance raised to $45.9-$46.2B, with management targeting FY30 'Rule of 50' combining double-digit growth and margin expansion.
Management priorities
- Roll out BrentForce Voice and Coworker agents across all Salesforce applications.
- Scale Headless 360 to additional surfaces and developer ecosystems.
- Deepen integration of Informatica data capabilities into the platform.
- Accelerate Slack AI features and increase AI-driven productivity tools.
- Achieve FY30 'Rule of 50' framework with double-digit revenue growth and margin expansion.
Sources
- Earnings call transcript and parsed analysis · 2026-05-28T01:17:42.971298+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-28T20:31:10.009471+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-28T20:31:10.007228+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.